VBI Vaccines company info

What does VBI Vaccines do?
VBI Vaccines (NASDAQ:VBIV) is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative vaccines for the prevention and treatment of infectious diseases and cancer. Their portfolio includes Sci-B-Vac®, a commercial third-generation hepatitis B vaccine, and an enveloped virus-like particle (eVLP) platform through which they develop vaccine candidates targeting cytomegalovirus (CMV), coronavirus (COVID-19), and other infectious diseases. VBI reflecting its commitment to advancing public health across global markets. The company aims to address some of the world's most pressing healthcare challenges by leveraging its expertise in vaccine research and development to bring new solutions to patients worldwide.
VBI Vaccines company media
Company Snapshot

Is VBI Vaccines a public or private company?

key
Ownership
Public

How many people does VBI Vaccines employ?

people
Employees
135

What sector is VBI Vaccines in?

pie chart
Sector
Health Care

Where is the head office for VBI Vaccines?

location pin
Head Office
Cambridge, United States

What year was VBI Vaccines founded?

founded flag
Year Founded
1965
What does VBI Vaccines specialise in?
/Vaccine Development /Immunotherapy Research /Hepatitis B Treatment /Cancer Vaccines /Meningitis Prevention /Virus-Like Particle Platform

What are the products and/or services of VBI Vaccines?

Overview of VBI Vaccines offerings
PreHevbrio, a 3-antigen hepatitis B vaccine for adults.
Sci-B-Vac, a commercial-stage hepatitis B vaccine offered in Israel and 10 other countries.
VBI-1901, a therapeutic vaccine candidate for glioblastoma.
VBI-1501, a prophylactic vaccine candidate for cytomegalovirus (CMV).
Pan-COVID-19 vaccine candidates, designed to provide broader protection against various coronavirus strains.

Who is in the executive team of VBI Vaccines?

VBI Vaccines leadership team
  • Mr. Jeffery R. Baxter FCMA
    Mr. Jeffery R. Baxter FCMA
    President, CEO & Director
  • Dr. David Evander Anderson
    Dr. David Evander Anderson
    Chief Scientific Officer
  • Dr. Francisco  Diaz-Mitoma FRCPC, M.D., Ph.D.
    Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D.
    Chief Medical Officer
  • Ms. Nell  Beattie
    Ms. Nell Beattie
    CFO, Head of Corporate Development & Director
  • Nicole  Anderson
    Nicole Anderson
    Director of Corporate Communications & Investor Relations
  • Ms. Athena  Kartsaklis
    Ms. Athena Kartsaklis
    Senior VP of Finance, Chief Compliance Officer & Principal Financial Officer
  • Mr. Avi  Mazaltov
    Mr. Avi Mazaltov
    Global Head of Manufacturing & GM of SciVac
  • Mr. Misha  Nossov
    Mr. Misha Nossov
    Senior VP of Global Commercial Supply Strategy & Head of Europe